These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2632085)

  • 1. Clinical evaluation of population pharmacokinetic parameters in phenytoin dosage adjustment.
    Yukawa E; Higuchi S; Aoyama T
    Chem Pharm Bull (Tokyo); 1989 Dec; 37(12):3363-6. PubMed ID: 2632085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of single-point phenytoin dosage prediction methods in pediatric patients.
    Yukawa E; Higuchi S; Aoyama T
    J Pharmacobiodyn; 1988 Nov; 11(11):736-43. PubMed ID: 3236206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of a new and simple technique for individualizing phenytoin dosage.
    Yukawa E; Higuchi S; Aoyama T
    J Pharmacobiodyn; 1989 Apr; 12(4):187-92. PubMed ID: 2795428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of single-point phenytoin dosage prediction techniques.
    Yukawa E; Higuchi S; Ohtsubo K; Aoyama T
    J Clin Pharm Ther; 1988 Aug; 13(4):293-305. PubMed ID: 3235480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic approach to a dosage regimen for phenytoin based on one-point, steady-state plasma concentration.
    Nakashima E; Matsushita R; Kido H; Nakamura M; Asahi M; Ichimura F
    Ther Drug Monit; 1995 Feb; 17(1):12-8. PubMed ID: 7725371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of methods for the prediction of phenytoin concentrations.
    Vázquez Rodríguez A; Santos Buelga D; Alonso González AC; Garcćia Sánchez MJ; Domínguez-Gil Hurlé A
    J Clin Pharm Ther; 1991 Feb; 16(1):55-62. PubMed ID: 2026669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenytoin dosage predictions in paediatric patients.
    Yuen GJ; Latimer PT; Littlefield LC; Mackey RW
    Clin Pharmacokinet; 1989 Apr; 16(4):254-60. PubMed ID: 2721089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-point feedback control method for phenytoin dosage adjustment.
    Yukawa E; Higuchi S; Aoyama T
    J Pharm Pharmacol; 1991 Jul; 43(7):499-503. PubMed ID: 1682464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenytoin dosage adjustment method using population clearance.
    Yukawa E; Higuchi S; Aoyama T
    Chem Pharm Bull (Tokyo); 1990 Feb; 38(2):510-2. PubMed ID: 2337967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting serum lithium concentration using Bayesian method: a comparison with other methods.
    Higuchi S; Fukuoka R; Aoyama T; Horioka M
    J Pharmacobiodyn; 1988 Mar; 11(3):158-74. PubMed ID: 3411433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new approach to establishing individualized maintenance doses of phenytoin.
    Bachmann K; Sullivan TJ; Schwartz J; Jauregui L
    Ther Drug Monit; 1985; 7(4):391-400. PubMed ID: 4082238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a bayesian pharmacokinetic program for phenytoin concentration predictions in outpatient population.
    Gaulier JM; Boulieu R; Fischer C; Mauguiere
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):295-300. PubMed ID: 9725496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimates of the population pharmacokinetic parameters and performance of Bayesian feedback: a sensitivity analysis.
    Vozeh S; Steiner C
    J Pharmacokinet Biopharm; 1987 Oct; 15(5):511-28. PubMed ID: 3694495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Bayesian graphic method for predicting individual phenytoin dosage schedule.
    Cai WM; Chu XM; Chen G
    Zhongguo Yao Li Xue Bao; 1991 Mar; 12(2):141-4. PubMed ID: 1776478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of four single-point phenytoin dosage prediction techniques using computer-simulated pharmacokinetic values.
    Toscano JP; Jameson JP
    Clin Pharm; 1986 May; 5(5):396-402. PubMed ID: 3720209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting phenytoin dosages using Bayesian feedback: a comparison with other methods.
    Yuen GJ; Taylor JW; Ludden TM; Murphy MJ
    Ther Drug Monit; 1983; 5(4):437-41. PubMed ID: 6659016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of a Bayesian dosing program for phenytoin.
    Privitera MD; Homan RW; Ludden TM; Peck CC; Vasko MR
    Ther Drug Monit; 1989; 11(3):285-94. PubMed ID: 2728087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian regression analysis of non-steady-state phenytoin concentrations: evaluation of predictive performance.
    Killilea T; Coleman R; Ludden T; Peck CC; Rose D
    Ther Drug Monit; 1989; 11(4):455-62. PubMed ID: 2741195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Bayesian feedback to forecast lidocaine serum concentration: evaluation of the prediction error and the prediction interval.
    Vozeh S; Uematsu T; Hauf GF; Follath F
    J Pharmacokinet Biopharm; 1985 Apr; 13(2):203-12. PubMed ID: 4057058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method for prediction of phenytoin levels in the acute clinical setting.
    Scheyer RD; Mattson RH
    Comput Biomed Res; 1991 Dec; 24(6):564-75. PubMed ID: 1769232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.